PS2 expression in BRCA1-associated breast cancers.

Abstract:

BACKGROUND:PS2-expression is controlled by estrogens and is a prognostic factor for long-term and post-relapse survival. Breast carcinomas associated with a BRCA1 mutation (BRCA1-BC'S) exhibit many specific features, particularly for ER expression. Our purpose was to determine if pS2-expression was different in BRCA1-BC's compared with sporadic breast cancers. MATERIALS AND METHODS:We studied, by immunohistochemistry pS2-cxpression in a series of 33 BRCA1-BC's and a series of 193 sporadic cases according to many parameter including hormone receptors (ER and PR). RESULTS:In BRCA1-BC's, pS2 was expressed in only 10/33 (30.3%) carcinomas, and 4/4 (100%) ER positive: among sporadic carcinomas, 133/193 (68.9%) cases were pS2-positive, 102/127(80.37%) ER positive; the difference was significant (p<0.0001). In univariate analysis, pS2-expression was correlated with many parameters including hormonal receptor status and absence of BRCA1 mutation. In multivariate analysis, pS2-expression was still correlated with ER but no more with BRCA1 mutation. CONCLUSION:pS2-expression in BRCA1-BC's was significantly different from sporadic breast cancer (p<0.0001) and correlated in a multivariate analysis with the same factors in sporadic and BRCA1-BC's but not with BRCA1 mutation.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Charafe-Jauffre E,Eisinger F,Mathoulin-Portier MP,Sobol H,Jacquemier J

subject

Has Abstract

pub_date

2001-07-01 00:00:00

pages

2877-81

issue

4B

eissn

0250-7005

issn

1791-7530

journal_volume

21

pub_type

杂志文章
  • Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

    abstract:UNLABELLED:In non-small cell lung cancer (NSCLC), pleural effusion is a frequently observed complication, and often provides a treatment difficulties. The aim of this study is to evaluate prognostic significance of pleural effusion in patients with NSCLC. MATERIALS AND METHODS:Seven hundred and eight untreated patient...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Naito T,Satoh H,Ishikawa H,Yamashita YT,Kamma H,Takahashi H,Ohtsuka M,Hasegawa S

    更新日期:1997-11-01 00:00:00

  • A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib.

    abstract:BACKGROUND:Sunitinib is a tyrosine kinase inhibitor (TKI) targeting tumour angiogenesis in patients with advanced renal cell carcinoma (RCC). Currently no universally agreed model exists correlating the expression of angiogenesis markers with the success of treatment. PATIENTS AND METHODS:We retrospectively analysed a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11315

    authors: Stubbs C,Bardoli AD,Afshar M,Pirrie S,Miscoria M,Wheeley I,Porfiri E

    更新日期:2017-01-01 00:00:00

  • Review of the Role of Radiomics in Tumour Risk Classification and Prognosis of Cancer.

    abstract::Radiomics, an emerging field in radiation therapy, is hypothesized to improve classification of tumour risk and prognosis. Despite encouraging results, there are issues of practicality and interpretation of radiomic data. This study investigates the emerging role of radiomics in tumour risk classification and prognosi...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.14350

    authors: Li Wen Y,Leech M

    更新日期:2020-07-01 00:00:00

  • Prognostic role of angiogenesis in colorectal cancer.

    abstract::The need for dependable prognostic markers in colorectal cancer, both in the advanced as well the as adjuvant setting, is greater than ever. The introduction of new chemotherapeutic agents in the clinic, with different mechanisms of action as well as different side-effect profiles, has made this even more important. A...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Papamichael D

    更新日期:2001-11-01 00:00:00

  • Adjuvant portal liver infusion with 5-fluorouracil and mitomycin in colorectal cancer. SAKK.

    abstract::Between 1981 and 1987, 533 patients from 9 institutions were entered in a randomized trial to assess the value of adjuvant perioperative portal infusion with Fluorouracil and Mitomycin as compared to radical surgery alone. Analysis of 469 evaluable patients at a median follow-up of 5.8 years revealed 110 recurrences i...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Weber W,Laffer U,Metzger U

    更新日期:1993-09-01 00:00:00

  • Invading basal cell carcinoma of the jaw: an under-evaluated complex entity.

    abstract::Basal cell carcinoma (BCC) is a locally invasive neoplasm, rarely metastatic, yet capable of significant local destruction and disfigurement. Invasion into the bone is uncommon and only a few cases of invasion into facial bones, but never to the mandible or maxilla, have been described. We report three patients with B...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nagler RM,Laufer D

    更新日期:2001-01-01 00:00:00

  • Bevacizumab as front-line treatment of brain metastases from solid tumors: a case series.

    abstract:BACKGROUND:Despite the large use of bevabizumab in the treatment of primary tumors of the brain, there is only limited experience with brain metastases (BM) and no experience in the treatment of previously untreated secondary brain lesions. PATIENTS AND METHODS:We treated patients with BM, not suitable for local treat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zustovich F,Ferro A,Lombardi G,Zagonel V,Fiduccia P,Farina P

    更新日期:2013-09-01 00:00:00

  • A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate.

    abstract::The circadian rhythm-modulated delivery of anticancer drugs has been shown to reduce toxicity and improve anticancer efficacy. The aim of this phase I trial was to compare the feasibility and tolerability of carboplatin (CBDCA) administered at circadian-modulated or flat infusion rate in 24 patients with advanced canc...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Natoli C,Salini V,Irtelli L,Martino MT,Garufi C,Grassadonia A,Fiorentino B,Iacobelli S

    更新日期:1996-05-01 00:00:00

  • Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency.

    abstract:AIM:To evaluate the frequency of loss of mediator of DNA damage checkpoint protein 1 (MDC1) protein expression in endometrial cancer (EC) and to determine whether loss of MDC1 is associated with certain clinicopathological parameters. MATERIALS AND METHODS:MDC1 expression was examined in 426 samples of EC. The nuclear...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13870

    authors: Merentitis D,Nguyen BD,Samartzis EP,Noske A,Brandt S,Dedes KJ

    更新日期:2019-12-01 00:00:00

  • The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.

    abstract::Constitutive activation of signal transducer and activator of transcription 3 (STAT3) has been indicated as a novel cancer drug target, since it plays an important role in diverse oncogenic processes including survival, cell proliferation and migration. Emerging STAT3 inhibitors have demonstrated efficacy in cancer ce...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11347

    authors: Tian J,Xiao H,Wu R,Cao Y,Li C,Xu R,Pierson CR,Finlay JL,Yang F,Gu N,Lin J

    更新日期:2017-02-01 00:00:00

  • Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.

    abstract:AIM:Maximal cytoreduction to minimal residual tumor is the most important determinant of prognosis in patients with advanced stage epithelial ovarian cancer (EOC). Preoperative prediction of suboptimal cytoreduction, defined as residual tumor >1 cm, could guide treatment decisions and improve counseling. The objective ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Gerestein CG,Eijkemans MJ,Bakker J,Elgersma OE,van der Burg ME,Kooi GS,Burger CW

    更新日期:2011-11-01 00:00:00

  • Cis-platinum (CDDP) plus etoposide (VP-16-213) and treatment of disseminated neuroblastoma.

    abstract::Ten patients with neuroblastoma were treated with a standard pulsed administration schedule of cis-platinum and etoposide (VP16-213). Two patients are experiencing good partial responses lasting over 8 months. One other patient had a partial response. Toxicity was mild and limited to high frequency hearing loss, tempo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Helson L

    更新日期:1986-11-01 00:00:00

  • Radiotherapy for early-stage primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.

    abstract:BACKGROUND:Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (POAML) is a rare disease. The purpose of this study was to evaluate the treatment outcome and patterns of failure of patients with early-stage POAML treated with radiotherapy. PATIENTS AND METHODS:From 1995 to 2008, 53 patients with early-st...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ohga S,Nakamura K,Shioyama Y,Sasaki T,Yoshitake T,Atsumi K,Terashima K,Asai K,Matsumoto K,Yoshikawa H,Kawano Y,Honda H

    更新日期:2013-12-01 00:00:00

  • Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.

    abstract::Ritonavir, a protease inhibitor, has been successfully applied in the treatment of HIV infection. Reports of dramatic improvement of AIDS-related cancers, such as primary central system lymphoma after radiation therapy as well as Kaposi's sarcoma, led to the recent discovery of the "non viral" antitumor activity of HI...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Maggiorella L,Wen B,Frascogna V,Opolon P,Bourhis J,Deutsch E

    更新日期:2005-11-01 00:00:00

  • Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways.

    abstract:BACKGROUND:Human choriocarcinoma is the most aggressive type of gestational trophoblastic neoplasia. The expression of epidermal growth factor receptor (EGFR) in choriocarcinomas is significantly higher than those of trophoblastic cells in healthy placentas. Lapatinib is a potent EGFR and human epidermal growth factor ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13355

    authors: Pires LV,Yi Y,Cheng JC,Pizzolato LS,Cordero E,Leung PCK,Brum IS

    更新日期:2019-05-01 00:00:00

  • Aloe vera Extract Suppresses Proliferation of Neuroblastoma Cells In Vitro.

    abstract:BACKGROUND/AIM:Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract. MATERIALS AND METHODS:Human neuroblast...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yonehara A,Tanaka Y,Kulkeaw K,Era T,Nakanishi Y,Sugiyama D

    更新日期:2015-08-01 00:00:00

  • Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma.

    abstract:AIM:The aim of the present study was to investigate the impact of cyclin E expression on cancer-specific survival, as well as on conventional clinocopathological and prognostic factors in endometrial endometrioid adenocarcinoma. MATERIALS AND METHODS:The study consisted of 211 patients surgically treated for endometri...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Santala S,Talvensaari-Mattila A,Soini Y,Santala M

    更新日期:2015-06-01 00:00:00

  • Effect of PKC412, an inhibitor of protein kinase C, on spontaneous metastatic model mice.

    abstract::We investigated the anti-metastatic effect of PKC412, a selective inhibitor of protein kinase C (PKC), on a spontaneous metastatic mouse model, which was prepared by inoculation with B16-BL6 mouse melanoma cells into the footpad of the right hind leg. At two weeks after inoculation, the primary tumor was amputated com...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nakamura K,Yoshikawa N,Yamaguchi Y,Kagota S,Shinozuka K,Kunitomo M

    更新日期:2003-03-01 00:00:00

  • Mono- or di-fluorinated analogues of flavone-8-acetic acid: synthesis and in vitro biological activity.

    abstract:BACKGROUND:Previously, the antitumour activity of some flavone-8-acetic acid (FAA) derivatives substituted with an acid function in position 2 of the benzene ring was evaluated. The most active compound resulted the one bearing a fluorine atom in position 7 of the flavone nucleus. In this paper, we evaluated new mono- ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Carrara M,Zampiron A,Barbera M,Caputo A,Bisi A,Gobbi S,Belluti F,Piazzi L,Rampa A,Valenti P

    更新日期:2005-03-01 00:00:00

  • Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.

    abstract:BACKGROUND/AIM:Malignant mesothelioma is a rare malignancy with limited therapeutic options. Exome-based next-generation sequencing (NGS) techniques may direct the future of molecular targeting and improve systemic therapies for patients with mesothelioma. MATERIALS AND METHODS:Eleven patients with NGS testing were se...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ugurluer G,Chang K,Gamez ME,Arnett AL,Jayakrishnan R,Miller RC,Sio TT

    更新日期:2016-05-01 00:00:00

  • Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.

    abstract:BACKGROUND:The search for biological markers to predict malignant disease and its recurrence, or to monitor the effectiveness of treatment is a continuous process in medicine. Several years ago, urinary excretion of cGMP in urine was found to be a sensitive predictor in the follow-up of ovarian cancer and of monitoring...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Orbo A,Hanevik M,Jaeger R,Van Heusden S,Sager G

    更新日期:2007-07-01 00:00:00

  • The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study.

    abstract:BACKGROUND/AIM:To evaluate the effectiveness of enzalutamide in Italian patients with hormone-refractory metastatic castration-resistant prostate cancer, progressing after chemotherapy with docetaxel plus prednisone. PATIENTS AND METHODS:A total of 60 patients were enrolled. Reduction in serum prostate-specific antige...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:10.21873/anticanres.11472

    authors: Cicero G,DE Luca R,Dorangricchia P,Dieli F

    更新日期:2017-03-01 00:00:00

  • Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro.

    abstract::Angiogenesis is critical for tumor growth and inflammation. Shiunko is a Chinese herbal ointment used for the treatment of burns in Japan. Its main ingredient is the root of Lithospermum erythrorhizon, which had been used for treating tumors and inflammation in China since the 5th century. We report here that shikonin...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hisa T,Kimura Y,Takada K,Suzuki F,Takigawa M

    更新日期:1998-03-01 00:00:00

  • Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia.

    abstract::Two metastasis-associated proteins, CD44v6 and NM23-H1, are expressed by normal lymphoid cells, the former serving as activation marker and the latter as a constitutive protein. CD44v6 is considered as a marker of poor prognosis of various hematological cancers but its expression was not demonstrated in childhood acut...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Magyarosy E,Sebestyén A,Timár J

    更新日期:2001-01-01 00:00:00

  • Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease.

    abstract::Decreased expression of VDUP1, which is an interesting stress response gene, has been shown in rat mammary tumors and has been discussed in relation to the development of the tumor. However, VDUP1 expression in clinical specimens of human cancer remains unclear. We employed TaqMan RT-PCR assay to investigate VDUP1 exp...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ikarashi M,Takahashi Y,Ishii Y,Nagata T,Asai S,Ishikawa K

    更新日期:2002-11-01 00:00:00

  • Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus.

    abstract::The expression of p53 and mdm-2 proteins was analysed in parrafin sections from 39 cases of Hodgkin's disease (HD) and compared to the presence of Epstein-Barr Virus (EBV). P53 protein was found in Hodgkin and Reed-Sternberg (HRS) cells in 12/39 cases. Mdm-2 protein was found in HRS cells in 10/39 cases. EBV-encoded E...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tzardi M,Kouvidou C,Panayiotides I,Koutsoubi K,Stefanaki K,Giannikaki E,Darivianaki K,Zois M,Eliopoulos G,Kakolyris S,Delides G,Rontogianni D,Kanavaros P

    更新日期:1996-09-01 00:00:00

  • Telomerase assay as a possible predictor of the response to anticancer chemotherapy.

    abstract:BACKGROUND:The correlation between telomerase activity and antitumor effects was investigated in cell lines of human gastric (MKN-28, MKN-45, and MKN-74) and breast (T-47D, MCF-7, ZR75-1) cancers to evaluate the possibility of utilizing this enzyme to predict tumor response to chemotherapy. MATERIALS AND METHODS:After...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Terashima M,Takiyama I,Uesugi N,Sasaki N,Takagane A,Hayakawa Y,Abe K,Araya M,Nishizuka S,Shimooki O,Nakaya T,Irinoda T,Yonezawa H,Oyama K,Saito K

    更新日期:2000-01-01 00:00:00

  • Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug.

    abstract::Selective expression of a therapeutic gene in tumors contributes to the efficacy and the safety of cancer therapy. Regulatory regions of genes that are preferentially expressed in tumors have been examined. The regions of the survivin gene exhibited the greatest activity in human hepatocellular carcinoma cells. Deleti...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawamura K,Yu L,Tomizawa M,Shimozato O,Ma G,Li Q,Sato A,Yang Y,Suzuki T,Abdel-Aziz NM,Tagawa M

    更新日期:2007-01-01 00:00:00

  • CA 125 measurement in the follow-up of breast cancer patients.

    abstract::During follow-up examinations for breast cancer the serum tumor marker CA 125 was measured routinely in the Universitätsfrauenklinik Erlangen. We found elevated CA 125 levels in 18 of 510 clinical asymptomatic patients. These patients were followed closely. A second malignant neoplasm was found in six of these patient...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Böhmer C,Jäger W,Lang N

    更新日期:1997-07-01 00:00:00

  • Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.

    abstract:BACKGROUND:Macrophage colony stimulating factor (M-CSF) binds to colony-stimulating factor-1 receptor (CSF-1R) and thereby stimulates the proliferation, differentiation and behaviour of monocytes, macrophages and their bone marrow progenitors. Previous studies have suggested that high expression of these markers is cor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Richardsen E,Sørbye SW,Crowe JP,Yang JL,Busund LT

    更新日期:2009-10-01 00:00:00